Suchergebnisse - (Subject:"Adalimumab")

PubPharm (12.467)

71

Adalimumab : A 'Maillon Faible' in the Treatment of Ulcerative Colitis?

enthalten in: Journal of Crohn's & colitis | 2024

von Roblin, X. | Paul, S.

CommentOn: J Crohns Colitis. 2024 Mar 1;18(3):341-348. - PMID 37691574

72

Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment

enthalten in: British journal of pharmacology | 2024

von Berkhout, L. | I'Ami, M. | Kruithof, S. | +11

73

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling

enthalten in: The Journal of investigative dermatology | 2024

von van Huizen, A. | Bank, P. | van der Kraaij, G. | +12

74

Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis : A Cross-Sectional Observational Study

enthalten in: The Journal of rheumatology | 2024

von Stamp, L. | Keating, P. | Frampton, C. | +5

75

Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment : a real-life cohort study on the effectiveness and drug survival over one-year

enthalten in: The Journal of dermatological treatment | 2024

von Liu, Y. | Hu, K. | Jian, L. | +3

76

Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials

enthalten in: Dermatology and therapy | 2024

von Egeberg, A. | Conrad, C. | Gorecki, P. | +4

77

Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events : A real-world finding

enthalten in: Immunity, inflammation and disease | 2024

von Yu, Z. | Gao, L. | Zang, Y. | +3

78

Drug Retention Time of Immunosuppressive Therapy in Behcet's Uveitis

enthalten in: Ocular immunology and inflammation | 2024

von Tran, D. | Rogers, S. | Lim, L.

79

Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis

enthalten in: World journal of gastrointestinal surgery | 2024

von Zheng, F. | Yang, K. | Min, W. | +5

80

Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically

enthalten in: Journal of Crohn's & colitis | 2024

von Wright, E. | Chaparro, M. | Gionchetti, P. | +10